text.skipToContent text.skipToNavigation
Need help? Please contact us

MSCGM™ SingleQuots™ Supplements and Growth Factors

MSCGM™ SingleQuots™ Supplements and Growth Factors

Catalog #: PT-4105

MSCGMTM SingleQuotsTM  Supplement Kit for proliferation of human bone marrow-derived mesenchymal stem cells.

Compare

Product Overview

The MSCGM hMSC SingleQuot Kit is a component of Lonza's MSCGM BulletKit (catalog no. PT-3001),a serum containing medium designed to proliferate human bone marrow derived mesenchymal cells in an undifferentiated state. The serum used in Lonza’s MSCGMTMhuman Mesenchymal Stem Cell Growth Medium BulletKitTM Medium is specifically screened to ensure that the serum neither promotes spontaneous differentiation of cells nor inhibits cell differentiation to osteogenic, chondrogenic, or adipogenic lineages (when properly stimulated with an appropriate differentiation media).

Lonza guarantees the performance of CloneticsTM/PoieticsTM cells only if appropriate CloneticsTM/PoieticsTM media and reagents are used exclusively and the recommended storage and use protocols are followed. Any modifications made to the recommended cell systems including the use of alternative media, reagents or protocols, will void cell and media performance guarantees. If you need assistance in selecting the appropriate media, reagents, or protocol, please contact Lonza Scientific Support. *List of cells generated from customer data. Lonza only routinely uses this medium with Lonza’s human bone marrow derived mesenchymal stem cells and can therefore only guarantee the successful use of this media with these cells.'

Request More Info
Return to Top

SDS, CoA, and Instructions

Certificate of Analysis (CoA)

Please enter Lot Number, including all zeros, located on the product label and please take into account that it is case sensitive.

Return to Top

Educational Material

Brochures, White Papers etc.

  • A 3D Bioprinted Model to Study Osteogenic Differentiation of Primary Mesenchymal Stem Cells

    Learn from this white paper how a 3D bioprinted model using hMSCs can be used for evaluation of bioink compatibility and bioprinting processes.
Return to Top